Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Expands Shoulder Product Line With the Introduction of a Proximal Humeral Fracture Plate System
Company Features System at 2013 American Association of Orthopedic Surgeons (AAOS) Annual Meeting
View HTML
Toggle Summary Integra LifeSciences Expands Its Product Offering for Spinal Deformity
Adds a New Cobalt Chrome Rod to Better Serve Surgeon Needs
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation Announces Changes to Its Board of Directors
PLAINSBORO, N.J., March 18, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the following changes to its Board composition: The Board of Directors appointed Mr. Lloyd W. Howell, Jr. as a Director of the Company, effective today, which will return the
View HTML
Toggle Summary Integra LifeSciences to Participate in Investor Conferences in March
PLAINSBORO, N.J., March 5, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks: At 1:00 PM ET on Tuesday, March 12, 2013, Ms. Angela Steinway, Head of Investor Relations of Integra,
View HTML
Toggle Summary Integra LifeSciences Reports Fourth Quarter 2012 Financial Results
Constant Currency Growth of 5.7% Introduces 2013 Full-Year Guidance PLAINSBORO, N.J., Feb. 21, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the fourth quarter ending December 31, 2012.
View HTML
Toggle Summary Integra LifeSciences to Participate in Investor Conferences in February
PLAINSBORO, N.J., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in February: - At 8:30 AM ET on Tuesday, February 26, 2013, Mr. Peter Arduini, President and Chief Executive Officer of
View HTML
Toggle Summary Integra LifeSciences Receives Warning Letter in Anasco, Puerto Rico, Manufacturing Facility
PLAINSBORO, N.J., Feb. 19, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that on February 14, 2013, it received a warning letter from the United States Food and Drug Administration (FDA) related to quality systems issues at its manufacturing
View HTML
Toggle Summary Integra LifeSciences Announces Three-Year Contract With Premier Healthcare Alliance
Provides Jarit(R), Ruggles(R)- Redmond(TM) and Padgett(R) Surgical Instruments
View HTML
Toggle Summary Integra LifeSciences Announces Launch of Integra(R) Flowable Wound Matrix in Europe for Diabetic Foot and Leg Ulcers
Device Awarded Most Innovative New Product by French Society of Reconstructive & Esthetic Plastic Surgery
View HTML
Toggle Summary Integra LifeSciences to Host Its Fourth Quarter 2012 Earnings Results Conference Call on February 21, 2013
PLAINSBORO, N.J., Jan. 15, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2012 financial results on Thursday, February 21, 2013. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
View HTML